EVALUATION OF APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN (ASC) AND B-CELL LYMPHOMA PROTEIN (BCL-6) IN RELATION TO PERIPHERAL BLOOD BIOMARKERS IN RELAPSING-REMITTING MULTIPLE SCLEROSI - Egyptian Knowledge Bank

295162

EVALUATION OF APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN (ASC) AND B-CELL LYMPHOMA PROTEIN (BCL-6) IN RELATION TO PERIPHERAL BLOOD BIOMARKERS IN RELAPSING-REMITTING MULTIPLE SCLEROSI

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Serum Soluble CD163 as a Marker of Activity in MS Patients

Article

Expression Profile of NLRP3 Inflammasome in Peripheral Blood Mononuclear Cells and Plasma Interleukin-22 Level in Multiple Sclerosis

Article

Estimation of Serum Interleukin- 12 (IL-12), Interleukin-17(IL-17) and Soluble Vascular Cell Adhesion Molecule (s-VCAM) in Multiple Sclerosis

Article

EVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS

Article

Serum osteopontin as a blood biomarker in relapsing–remitting multiple sclerosis Egyptian patients

Article

Evaluation of leptomeningeal enhancement in patients with multiple sclerosis

Article

CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity

Article

Evaluation of MIF as a Diagnostic Biomarker in Cases with Ankylosing Spondylitis

Article

CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity

Article

The association of Inflammatory markers and ICAM-1 with neurological disabilities in Relapsing Remitting Multiple Sclerosis (RRMS) patients